StockData
Carlsmed, Inc. logo

Carlsmed, Inc. (CARL) stock

CARLNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 5/30118% above fair value
$17.74+0.39 (+2.25%)

Close on Nov 17, 2026Market cap $484.35MP/E –Yield –

Carlsmed ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

Carlsmed's ebitda for the twelve months ending Jun 30, 2026 was -$38.26M. For fiscal 2025 it was -$30.29M.

Annual ebitda

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$30.29M–
FY2024Dec 31, 2024-$23.98M–

Quarterly ebitda

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$10.91M–
Q1 FY2026Mar 31, 2026-$9.18M–
Q4 FY2025Dec 31, 2025-$9.22M–
Q3 FY2025Sep 30, 2025-$8.95M–
Q2 FY2025Jun 30, 2025-$6.44M–
Q1 FY2025Mar 31, 2025-$5.68M–
Q4 FY2024Dec 31, 2024-$4.66M–
Q3 FY2024Sep 30, 2024-$7.74M–

More Carlsmed figures

See a number that looks wrong?